Physician profile
Maria D Aguinaga
NPI 1023338902
$17,603.82
in general payments reported to CMS, 2019-2025
34 companies · $4,990 in 2025
The $4,990 reported for 2025 was more than what 99% of Undersea and Hyperbaric Medicine (Emergency Medicine) providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,601 · 2020: $928 · 2021: $3,588 · 2022: $1,750 · 2023: $2,226 · 2024: $2,520 · 2025: $4,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,003 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,002.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,733.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,771.22 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix |
| Bsn Medical INC | $2,733.55 | 2025 | |
| Urgo Medical North America, LLC | $2,032.21 | 2022-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Hydrofera LLC | $1,724.47 | 2021-2025 | Hydrofera Blue, Hydrofera Blue Ready - Border, Cutimed Sorbact |
| Organogenesis INC. | $1,409.99 | 2019-2025 | Apligraf, Puraply Wound Matrix, Affinity |
| Tactile Systems Technology INC | $696.53 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Kci USA, INC. | $487.76 | 2019-2023 | Activ.A.C., V.A.C. Veraflo Cleanse Choice |
| Melinta Therapeutics, LLC | $323.81 | 2019-2023 | Kimyrsa |
| Misonix INC | $294.85 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $294.10 | 2022-2025 | Nuzyra |
| Kerecis Limited | $293.57 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Aroa Biosurgery Incorporated | $271.84 | 2019-2025 | |
| Reddress USA, INC. | $228.08 | 2023-2025 | Actigraft |
| Allergan, INC. | $226.16 | 2019-2021 | |
| Abbvie INC. | $179.61 | 2021-2023 | Dalvance, Teflaro |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $179.26 | 2020 | |
| Sechrist Industries INC | $154.77 | 2024 | |
| Reprise Biomedical, INC. | $140.48 | 2019-2025 | Miro3d |
| Bioventus LLC | $135.90 | 2023 | |
| Lifenet Health | $134.16 | 2023 | |
| Pfizer INC. | $118.13 | 2019 | |
| Next Science LLC | $116.05 | 2023 | Blastx, Surgx, Xperience |
| Solventum Corporation | $112.78 | 2024-2025 | V.A.C. Veraflo, 3m Cavilon |
| E.R. Squibb & Sons, L.L.C. | $95.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $91.77 | 2022 | |
| Novartis Pharmaceuticals Corporation | $90.28 | 2019 | |
| Mimedx Group, INC. | $68.74 | 2025 | |
| Bard Peripheral Vascular, INC. | $46.61 | 2025 | Fluency Endovascular Stent Graft |
| Abiomed | $41.20 | 2025 | |
| Convatec INC. | $28.34 | 2022-2023 | |
| Medline Industries Lp | $26.54 | 2023-2025 | |
| Coloplast Corp | $20.28 | 2025 | |
| Imbed Biosciences INC. | $19.17 | 2022 | |
| Hartmann USA, INC. | $16.29 | 2025 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Aguinaga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.